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Deiodinases (D1, D2, and D3) are selenoproteins involved in
thyroid hormone metabolism. Generation of the active hor-
mone T3, from T4, is carried out by D1 and D2, whereas D3
degrades both hormones. The identity of the cloned D2 as a
selenoprotein is well supported by biochemical and physio-
logical data. However, an alternative view has proposed that
type 2 deiodinase is a nonselenoprotein complex containing a
putative T4 binding subunit called p29, with an almost iden-
tity in sequence with the Dickkopf protein Dkk3.
To explore a possible functional relationship between p29
and D2, we have compared their mRNA expression patterns in
the rat brain. In brain, parenchyma p29 was expressed in
neurons. High expression levels were found in all the regions
of the blood-cerebrospinal fluid (CSF) barrier. p29 was
present in different types of cells than D2, with the exception
of the tanycytes. Our data do not support that p29 has a func-
tional relationship with D2. On the other hand, expression of
p29 in the blood-CSF barrier suggests that it might be involved
in T4 transport to and from the CSF, but further studies are
needed to substantiate this hypothesis. (Endocrinology 144:
1045–1052, 2003)
DEIODINASES ARE A FAMILY of selenoproteins in-volved in thyroid hormone (TH) metabolism and,
specifically, in generation of T3 from T4 and degradation of
iodothyronines [reviewed by Bianco et al., 2002 (1); Leonard
and Ko¨hrle, 2000 (2); Ko¨hrle, 1999 (3); and Leonard and
Visser, 1986 (4)]. Three deiodinases have been identified and
cloned (5–7) and are known as type 1 (D1), type 2 (D2),
and type 3 (D3) deiodinases. Generation of the active hor-
mone T3 from T4 in target tissues is performed by D1 and D2.
In rodents, D1 and D2 have similar contributions to circu-
lating T3. D2 is additionally involved in the intracellular
generation of T3 in target tissues such as brain, pituitary and
brown adipose tissue. In humans, D2 is also expressed in
skeletal muscle and may also contribute to circulating T3 (8).
Degradation of T4 and T3 to reverse T3 and 3,3diiodothy-
ronine, respectively, is carried out by D1 and D3 (9).
Deiodinases are selenoproteins, which contain the rare
amino acid selenocysteine. The selenoprotein mRNAs con-
tain a bifunctional UGA codon that signals either the usual
stop codon, or the amino acid selenocysteine. For the latter
function, it needs Se and a special sequence in the 3-
untranslated region called the selenocysteine insertion se-
quence element. The selenoprotein nature of D1 and D3 has
not been a matter of discussion (7, 10, 11). Concerning D2, the
identification of a selenocysteine insertion sequence element
in the human D2 (12), robust biochemical data (13), and
results from knockout animals (14) solidly support the iden-
tity of the cloned D2 as a physiological selenoprotein with D2
activity. Despite this, an alternative view has proposed that
D2 is a nonselenoprotein, multiprotein complex of about 200
kDa consisting of catalytic and T4-binding subunits (15, 16).
Furthermore, the cloned D2 mRNA would not encode the
physiological enzyme. Reasons to support these views in-
clude a lack of effect of Se deficiency on D2 activity (17–19),
the low inhibition of type 2 deiodinase activity by gold in
contrast with other selenoproteins (20), and the failure to
detect any protein with antibodies generated from the con-
ceptual translation of the cloned D2 cDNA (21). Along this
reasoning, a putative T4-binding subunit identified by affin-
ity labeling as a 29-kDa protein (p29) was recently cloned
from rat (22). The cDNA encoding p29 has a high degree of
similarity to members of the Dickkopf (Dkk-1–4) family of
secreted glycoproteins involved in regulation of dorsoven-
tral patterning during embryonic development (23, 24). In
particular, rat p29 has 87% similarity at the nucleotide level
with mouse Dkk-3, a protein with tumor suppressor activity
(25) expressed at higher levels in heart, brain and spinal cord
(23). Data supporting a role for p29 in TH metabolism include
the enhancement of D2 activity when transfected to cultured
astrocytes (22).
Expression of D2 is particularly important in the brain
given the developmental effects of TH and the fact that most
T3 present in brain is formed locally from T4 because of D2
activity (26). Expression and activity of D2 in brain are reg-
ulated by TH concentrations such that they increase in hy-
pothyroidism and decrease in hyperthyroidism as a com-
pensatory mechanism to maintain normal T3 concentrations
(27–31). D2 is expressed predominantly in astrocytes and, in
much higher amounts, in the tanycytes lining the walls of the
third ventricle (32, 33). Expression of D2 mRNA correlates
with deiodinase activity measured in punches from different
brain regions (34). We reasoned that, if there is any functional
relationship between p29 as a putative T4-binding subunit of
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a deiodinase multiprotein complex and D2, the expression of
both molecular species would show a large degree of overlap
among regions and cell types of brain tissue. To this end, we
have simultaneously analyzed the distribution of p29 and D2
mRNAs by in situ hybridization. Our results indicate that p29
is expressed in different types of cells than D2, with the
notable exception of the tanycytes. p29 is expressed with a
neuronal-like distribution and is also found in cells of the
blood-CSF barrier. Our data do not support that p29 has a
functional relationship with D2, but open the possibility that
it may be involved in T4 transport to and from the CSF
contributing to T4 availability within the brain.
Materials and Methods
Animals and treatments
Male Wistar rats 16 and 60 d old (P16 and P60) were used in these
studies. In addition, hypothyroid male Wistar P16 rats were used. To
induce hypothyroidism, pregnant dams were given 0.02% 2-mercapto-
1-methylimidazole (Sigma, St. Louis, MO) and 1% sodium perchlorate
in the drinking water ad libitum from gestational d 10 and throughout
lactation until the neonates were killed at P16. This protocol causes
severe hypothyroidism as shown by reduced growth rate and large
decreases of T4 and T3 concentrations in serum and cerebral cortex (35).
Animals were under temperature (22  2 C) and light (12-h light, 12-h
dark cycle; lights on at 0700 h) controlled conditions and had free access
to food and water. Animal care procedures were conducted in accor-
dance with the guidelines set by the European Community Council
Directives (86/609/EEC).
Tissue processing
Rats were anesthetized by ip injection of a mixture of Ketamine (4
mg/100 g body weight) and Metedomidine (15 mg/100 g body weight),
and the animals were perfused transcardially with fixative [4% para-
formaldehyde in 0.1 m phosphate buffer, pH 7.4]. Brains were removed,
post fixed in the same solution overnight, and cryoprotected at 4 C for
2–3 d in the paraformaldehyde solution containing 30% sucrose. They
were then frozen in dry ice and coronal sections 25 m thick were
obtained in a cryostat. The sections were stored at 70 C in a cryopro-
tective solution containing 30% ethylenglycol, 30% glycerol, and 40%
0.1 m phosphate buffer.
RNA probes
A specific p29 probe (nucleotides 1172–1499, 327 bp) was designed
based on the published rat cDNA sequence (accession no. AF245040)
(22), and the DNA template isolated by RT-PCR. Total cerebral cortex
RNA was isolated from P16 rats using TRIzol reagent (Life Technologies,
Inc.) according to the manufacturer’s instructions. The cDNA was ob-
tained with the cDNA synthesis kit (Amersham Pharmacia Biotech,
Buckinghamshire, UK). The following primers were used to amplify the
p29 specific sequences: forward (1172–1191), 5-CTTGA CAAGG TA-
CAG TGCAG-3; reverse (1480–1499), 5-CAGGA GCTAT GCTGC
TCTTG-3. The PCR products were cloned in the pGEM-T easy vector
(Promega Corp., Madison, WI). The sense (SP6 RNA polymerase) and
antisense (T7 RNA polymerase) riboprobes for in situ hybridization were
synthesized in the presence of 35S-uridine triphosphate (UTP) (NEN Life
Science Products) or digoxigenin-UTP (Roche Molecular Biochemicals,
Mannheim, Germany) by in vitro transcription.
In addition to the above probe, two 50-oligomer oligonucleotides,
1) 5-GGAGC TAAAA CACTG GGGAC TGGGG GAGTA ATGTG TG-
GAA GGCCA CAAGAG-3; and 2) 5-CCTGC CACGC CTGTC TTTCT
TTCCT AAGCC AGAGA AGTGG GGCAG CTGGA-3, from the p29
sequence were used as probes in in situ hybridization experiments. The
oligonucleotides were labeled with 35S--deoxy-ATP (Dupont, Wil-
mington, DE) and terminal transferase (Roche Molecular Biochemicals).
A specific D2 antisense riboprobe was synthesized with SP6 RNA
polymerase in the presence of 35S-UTP (Dupont) using a 366-bp
DNA template spanning nucleotides 535–901 (32) from the rat D2 cDNA
sequence (5).
Northern blot analysis
The specificity of the probes was tested by Northern blot analysis with
total RNA from cerebellum and cerebral cortex from P16 rats isolated as
above. Northern blots were prepared using nylon membranes (Nytran,
Schleicher & Schuell, Inc., Keene, NH). Ten micrograms of total RNA
were fractionated on formaldehyde-agarose gels and transferred to the
filters using standard techniques (36). The cDNA radioactive probes
were labeled with the kit rediprime II (Amersham Pharmacia Biotech)
using 32P-deoxy-CTP. The filter was hybridized with the same probe
used in the in situ hybridization analysis (327-bp probe spanning nu-
cleotides 1172–1499 from the rat p29 cDNA). As control for the amount
and integrity of the RNA present on the filters, blots were stained in
0.02% methylene blue solution in 0.3 m sodium acetate and then hy-
bridized with a probe specific for the housekeeping gene glyceralde-
hyde-3-phosphate dehydrogenase.
In situ hybridization with radioactive probes
The detection of p29 and D2 mRNAs with 35S-labeled riboprobes was
performed on free-floating sections according to protocols previously
described in detail (37, 38). Briefly, the sections were pretreated in
different solutions for 10 min at room temperature each: permeabilized
with 0.1% Triton X-100 in PBS, deproteinized with 0.2 n HCl, acetylated
with 0.25% acetic anhydride in 0.1 m triethanolamine buffer (pH 8.0),
postfixed in fixative, and washed in PBS. Prehybridization was per-
formed at 55 C for 3–5 h, in a solution containing 50% formamide, 10%
dextran sulfate, 5Denhardt’s solution, 0.62 m NaCl, 50 mm DTT, 0.01 m
EDTA, 0.02 m 1,4-piperazinediethanesulfonic acid (pH 6.8), 0.2% sodium
dodecyl sulfate, 250 g/ml salmon sperm DNA, and 250 g/ml yeast
tRNA. Hybridization was performed in this solution at 55 C for 16 h,
with the 35S-labeled riboprobe at 1.6  107 cpm/ml. Excess probe was
removed with 2 saline sodium citrate (SSC; 1 SSC is 0.015 m NaCl,
0.0015 m Na citrate) containing 10 mm -mercaptoethanol at room tem-
perature for 30 min, followed by incubation with 4 g/ml ribonuclease
A in 0.5 m NaCl, 0.05 m EDTA, 0.05 m Tris-HCl (pH 7.5) at 37 C for 1 h.
Stringency washes were carried out in 0.5 SSC, 50% formamide, 10 mm
-mercaptoethanol at 55 C for 2 h, and then in 0.1 SSC, 10 mm -mer-
captoethanol at 68 C for 1 h.
To detect p29 mRNA with oligonucleotide probes, the free-floating
sections were only acetylated, postfixed, and hybridized for 20 h at 42
C with 35S-labeled oligonucleotides at 2 106 cpm/ml. Excess probe was
removed with 1 SSC. Stringency washes were carried out in 1 SSC
at 42 C and 0.1 SSC at room temperature.
In situ hybridization histochemistry and
immunohistochemistry
To analyze the cell types that express p29 mRNA, a combination of
in situ hybridization histochemistry and immunohistochemistry was
performed in the same tissue section, using a double-labeling technique
previously described (39). Briefly, after hybridization and washes, the
free-floating sections were incubated sequentially with the primary an-
tibody overnight at 4 C, then with a biotinylated secondary antibody
(1:200, Vector Laboratories, Burlingame, CA) for 1 h at 4 C and finally
processed by the avidin-biotin-peroxidase method using the Vectastain
Elite ABC Kit (Vector Laboratories, PK-6100) with 0.05% 3,3-diamino-
benzidine tetrahydrochloride (Sigma, D-5905) and H2O2 as peroxidase
substrates. Omitting the primary antibody resulted in negligible color
development. The antibodies used were a polyclonal antibody against
glial fibrillary acidic protein (1/2000; Dakopatts, M-0725) to detect as-
trocytes; a mouse monoclonal antibody antiparvalbumin (1/1000;
Sigma, C-8666) and a mouse monoclonal antibody anticalbindin (1/
4000; Sigma, C-9848) to localize subsets of interneurons.
Double in situ hybridization with riboprobes
For cellular colocalization studies, the free-floating sections were
processed as described above but hybridized with both the p29-specific
digoxigenin-labeled riboprobe at 200 ng/ml and the D2-specific 35S-
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labeled riboprobe at 1.6  107 cpm/ml. After several washes with
PBS, the sections hybridized with digoxigenin-labeled riboprobe
were preincubated with blocking solution, incubated with antidigoxi-
genin alkaline phosphatase conjugated antibody (1:5000, Roche) for 2 h
and developed with 4-nitroblue tetrazolium–5-bromo-4-chloro-3-
indolyl-phosphate (Roche) following the manufacturer’s instructions.
Final processing
In all cases, the sections were mounted on coated slides, dehydrated,
air-dried, and exposed to Kodak Biomax MR film (Eastman Kodak,
Rochester, NY) for 6–12 d for p29 expression analysis and for 3 wk for
colocalization studies. For cellular resolution, the sections were dipped
in Hypercoat LM-1 photographic emulsion (Amersham Pharmacia Bio-
tech), exposed for 20–30 d in the cold, developed with D19, fixed,
dehydrated, and coverslipped. When only in situ hybridization was
performed, the sections were counterstained with Richardson’s blue.
Cytoarchitectonic analysis
The autoradiographic films were scanned in a Nikon Coolscan II slide
scanner (Nikon Corp., Tokyo, Japan), at a resolution of 400 pixels/inch
and printed. Optical observations and photographs were made in a Zeiss
Axiophot microscope (Carl Zeiss, Oberkochen, Germany) and a Nikon
digital camera Dn100. For the identification of brain structures, the atlas
of Paxinos and Watson was followed (40).
Results
Regional distribution of p29 mRNA
Expression of p29 in rat brain was analyzed by in situ
hybridization using a 327-nucleotide riboprobe synthesized
from a DNA template encompassing nucleotides 1172–1499
from the published cDNA sequence. The probe hybridized
to a 3.5-kb mRNA in Northern blots of cerebral cortex and
cerebellum (Fig. 1A). Leonard et al. (22) reported a similar
size mRNA in astrocytes. The distribution of p29 mRNA in
brain slices obtained with this probe was identical to that
using the oligonucleotide probes from other regions of the
cDNA as described in the previous section (not shown). The
data reported below were obtained using the 327-nucleotide
riboprobe. A sense probe gave no signal (Fig. 1B).
p29 expression was analyzed in brains of euthyroid (Fig.
1, C1–C6) and hypothyroid (Fig. 1, D1–D6) rats on P16, an age
when D2 expression and activity are highest in the brain (41).
Further analysis using P60 euthyroid rats showed essentially
the same pattern as on P16 (not shown). Briefly, highest p29
expression was found in the hippocampus, the neocortex,
and the epithelial lining of the ventricles. p29 mRNA was
also abundant in the choroid plexuses and the leptomenin-
ges. Lower levels were found in the cerebellum and in several
thalamic nuclei related to the reticular formation. White mat-
ter areas, such as the corpus callosum, were not labeled. The
caudate and the olfactory bulb were almost devoid of p29
mRNA.
Looking at p29 expression in more detail, we found that
in the cerebral cortex, p29 was mainly expressed in archicor-
tex (hippocampus) and neocortex but hardly in paleocortex
(olfactory cortex). In the hippocampus, there was an ex-
tremely high signal in the CA3 and CA4 regions of Ammon’s
horn, whereas CA1 and dentate gyrus were moderately la-
beled (Fig. 1, C4). Expression in the neocortex took place in
all layers, except in layer I. There was a strong hybridization
signal in layer IV and deep layer VI in frontal, agranular and
parietal cortices (Fig. 1, C1–C4). However, in cingulate and
retrosplenial cortices highest expression was localized in
layer II. The piriform cortex showed little hybridization de-
spite its high cellular density (Fig. 1, C2–C4).
It was noteworthy that a considerable hybridization signal
was present in the lining of the ventricles, with the strongest
signal in the third ventricle (Fig. 1, C4–C5). There was also
significant hybridization signal in the other areas of the
blood-CSF barrier: the choroid plexuses and the leptome-
ninges. Due to the floating hybridization technique, the lep-
tomeninges were not well preserved in all the sections, but
they appeared clearly labeled as shown in Fig. 1 (arrows).
Other sites of p29 expression were the basolateral amygda-
loid nucleus (Fig. 1, C4) and some nuclei related to the re-
ticular formation (paraventricular, laterodorsal, reticular,
and parafascicular thalamic nuclei; some of them are shown
in Fig. 1, C4–C5). p29 was also expressed in the dorsal lateral
geniculate nucleus and in the zona incerta (Fig. 1, C5). In the
cerebellum, there was a higher signal in the internal granular
layer and in the lining of the fourth ventricle. There was also
an appreciable signal in the facial nuclei (Fig. 1, C6).
In previous studies, we found that D2 mRNA was in-
creased in specific brain regions in response to hypothyroid-
ism (31). Regarding p29, there was no difference in p29
expression in most regions (Fig. 1, D1–D6), except for a
slightly increased signal in the choroid plexuses (Fig. 1,
D3–D5).
To obtain microscopic resolution, we performed emulsion
autoradiography and counterstained the sections. Figure 2
shows bright and dark field images (A–E and A–E, respec-
tively) of relevant sites of p29 expression. In the somatosen-
sory cortex (Fig. 2, A and A), there was no signal in layer I
and few silver grains in layers II–III, whereas layer V shows
a medium label. The strongest radioactive signal was seen
over layer IV and deep layer VI. In the hippocampus (Fig. 2,
B, B, C, and C), there was a high density of silver grains in
the pyramidal layers of the CA3 and CA4 regions, with much
less hybridization signal in the granular layer of the dentate
gyrus. There were also groups of silver grains that formed the
shape of individual cellular somas in the polymorphic layer
of the dentate gyrus; these cells were characterized as neu-
rons (see next section).
There was a discrete signal over the lining of the third
ventricle (Fig. 2, D and D); the silver grains were located in
the soma of ependymocytes and tanycytes and in their pro-
cesses to the ventricle as shown at higher magnification in
Fig. 2, E and E. The autoradiographic analysis in hypothy-
roid rat brain showed an almost identical p29 expression to
that found in normal brain (data not shown).
Cellular characterization of p29 expressing cells
The cells expressing p29 mRNA were characterized by
analyzing their morphology and the expression of specific
protein markers. To achieve this, we performed in situ hy-
bridization combined with Nissl staining or with immuno-
histochemistry in the same tissue slice. We used antibodies
against glial fibrillary acidic protein expressed mainly by
astroglial cells, and against calbindin and parvalbumin ex-
pressed by subpopulations of interneurons.
Besides expression in ependymocytes and tanycytes, as
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mentioned above, the data indicate that p29 is expressed in
neurons, mainly pyramidal neurons. As shown above, p29
expression in the hippocampus took place mainly in pyra-
midal layers. This was confirmed by emulsion photography
that showed the hybridization grains over pyramidal cells
(Fig. 3A). Also in the neocortex, the silver grains were as-
sociated to neurons. p29 expression was strong in layer IV
and deep layer VI. In layer IV and VI, the grains were ag-
gregated resembling round shapes of large and medium
sizes (Fig. 3B). Many calbindin positive interneurons express
p29 in layer IV and some of them in layer VI (Fig. 3E) and in
the polymorphic layer of the dentate gyrus. However, the
parvalbumin immunopositive cells in the neocortex did not
contain silver grains (Fig. 3F). Neuronal expression of p29
was also strongly supported by the finding of silver grains
over large neurons of the reticular formation giganto cellu-
laris in the medulla (Fig. 3C). The white matter was devoid
of p29 mRNA, and there was no signal over oligodendro-
cytes recognized by their morphology and disposition in
linear arrays (Fig. 3B). Figure 3D shows p29 expression in
ependymocytes and the choroid plexus.
Lack of colocalization of p29 and D2 mRNAs
To assess a possible functional relationship between p29
and D2, we examined whether or not both molecules were
simultaneously present in some subsets of cells. To this end,
we used a D2 radioactive probe together with a p29 probe
labeled with digoxigenin. The mixed probes were used for in
situ hybridization on P16 brain slices. Regional expression of
D2 was identical to that previously reported (31). As was
expected from the results described above regarding p29
expression, both mRNAs were located in different cellular
groups throughout the brain. At the regional level, D2 was
expressed in some regions which lack p29, such as the cau-
date, whereas others, such as the amygdala expressed p29
but not D2 (not shown). D2 was not expressed in the ependy-
mocytes lining the ventricles, the leptomeninges, and the
choroid plexuses, places with prominent p29 expression
(Fig. 1).
In other regions, such as the neocortex and the hippocam-
pus both mRNAs were expressed, but in different layers or
cell types. Figure 4, A and A, shows that layer I of the
neocortex expressed D2 but not p29, which was present in
neurons at the upper border of layer II. These neurons did
not express D2. In the hippocampus, D2 was clearly present
in the molecular layer of the dentate gyrus, where it was
expressed in astrocytes, whereas p29 was expressed in the
granular and pyramidal layers (Fig. 4, B and B).
The only cells that appeared to express both mRNAs were
the tanycytes, a specialized type of glial cells, which replace
the ependymocytes in the bottom of the third ventricle (Fig.
a hypothyroid rat. Cg, Cingulated cortex; Pir, piriform cortex; IV and VI,
layers of the neocortex; Rc, retrosplenial cortex; LV lateral ventricle;
CPu, caudate-putamen; CA3, field 3 of Ammon’s horn; Rt, reticular
thalamic nucleus; BL, basolateral amygdaloid nucleus; 3V and 4V, third
and fourth ventricles; PF, parafascicular nucleus; DLG, dorsolateral
geniculate nucleus; ZI, zona incerta; igl, internal granular layer; VII,
facial nucleus; ChP, choroid plexuses. Arrows in C1, C3, D1, D2, and D4
point to the meninges. Scale bar, 0.2 cm.
FIG. 1. Regional expression of p29 in brain of normal and hypothyroid
rats. A, Northern blot of p29 in the cerebellum (Cb) and cerebral cortex
(Cx); the arrows show the size of RNA standards. The size of the p29 band
was read from the regression line obtained in a semilog plot of standard
mRNA sizes vs. distance migrated in the electrophoresis gel. A glycer-
aldehyde-3-phosphate dehydrogenase probe was used for control of RNA
loading. B, Brain slice hybridized with a sense riboprobe. In panels C and
D, the sections are organized from anterior to posterior levels. C1–C6,
Expression of p29 in slices from an euthyroid rat. D1–D6, Expression in
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4, C and C). The tanycytes are the cells with the highest D2
expression in brain (32, 33). However, whereas p29 mRNA
was present mainly in the tanycyte bodies, D2 was present
in the tanycyte processes, and their feet near the median
eminence. In the median eminence, p29 expression was high
in the leptomeninges (Fig. 4, C and C).
Discussion
The goal of this work was to explore a possible functional
relationship between D2 and the putative T4-binding protein
p29 in vivo. Studies in vitro indicate that p29 overexpression
increases D2 activity 100 times, and the use of specific an-
tibodies against p29 led to inmunoprecipitation of 5-deio-
dinase activity both in astrocyte cultures and in microsomal
fractions isolated from hypothyroid BAT and cerebral neo-
cortex. In addition, direct injection of recombinant Ad5-p29
virus particles in the neocortex slightly increased (2) 5-
deiodinase activity (22).
As an initial approach, we performed in situ hybridization
studies to determine whether the two genes were expressed
in the same groups of cells in the brain. Studying mRNA
distribution has obvious limitations. However, the study of
D2 protein distribution is hampered by lack of antibodies
suitable for immunohistochemistry and probably extremely
low cellular concentrations of the protein. Nevertheless, the
regional heterogeneity of the central nervous system allows
inferring the existence of functional relationships among dif-
ferent molecules from expression correlates. As described
previously, D2 was mainly expressed in the tanycytes lining
the inferior walls of the third ventricle, and also in brain
structures such as the cerebral neocortex, hippocampus, cau-
date, midbrain, brain stem, and cerebellum (32, 33). p29 was
expressed in the neocortex, hippocampus, cerebellum, amyg-
dala, and some thalamic nuclei related to the reticular for-
mation. It was absent from the caudate, one of the regions
were D2 is expressed. Other sites of prominent p29 expres-
sion include the leptomeninges, the epithelial cells of the
choroid plexuses, the ependimocytes, and the tanycytes. In
regions where both D2 and p29 were expressed, they were
present in different layers or in different groups of cells. D2
is expressed in astrocytes (32), whereas p29 is localized in
neurons. The only cells that appeared to coexpress both
mRNAs were the tanycytes, but given the lack of coexpres-
sion elsewhere, it is doubtful that the eventual presence of
both proteins in the tanycytes reflects any functional relation
between them.
D2 expression in rat brain is influenced by developmental
and physiological factors. Enzyme activity and mRNA abun-
dance are highest during the postnatal period than in fetal life
and are also regulated by the thyroidal status. Hypothyroid-
ism induced an increase in D2 activity in total brain and
cerebral cortex (27, 28, 30). Iodine deficiency also increased
D2 mRNA and activity in brain (29, 42). As we have shown
previously, profound hypothyroidism induced an increased
D2 mRNA in the relay nuclei of somatosensory and auditory
pathways, which could be thought as being especially pro-
tected from low T3 by an increased D2 activity (31). D2
mRNA expression also increases severalfold in the tanycytes
after hypothyroidism (33). In contrast, except for a slightly
FIG. 2. Bright field (left panels) and dark field (right panels) micro-
photographs of p29 expression. In situ hybridization was performed
using a p29 radioactively labeled riboprobe. After hybridization, the
sections were covered with photographic emulsion, exposed, and de-
veloped to reveal the silver grains (white signal in right panels). The
sections were then counterstained to reveal the cellular distribution
(left panels). Layers of cerebral neocortex are labeled I to VI. DG,
Dentate gyrus; CA1–4, fields of Ammon’s horn; Po, polymorphic layer
of the dentate gyrus; 3V, third ventricle; ME, median eminence; Tn,
tanycytes. Scale bars in A and B, 500 m; in C and D, 100 m; and
in E, 50 m.
Montero-Pedrazuela et al. • p29 and D2 Expression in Rat Brain Endocrinology, March 2003, 144(3):1045–1052 1049
 by on May 25, 2010 endo.endojournals.orgDownloaded from 
increased expression of p29 in the choroid plexuses, expres-
sion of p29 was not altered by hypothyroidism in most
regions.
It is intriguing that p29 was expressed all along the whole
cell layer covering the ventricles, as ependimocytes and ta-
nycytes, and also forming the epithelial layer of the choroid
plexuses and the arachnoid membrane. The mechanisms of
T4 transport in the brain are at present not well understood.
FIG. 3. Expression of p29 at the cellular level. In situ hybridization using emulsion microphotograpy was combined with Nissl staining (A–D)
or with immunohistochemistry with specific antibodies for calbindin (E) or parvalbumin (F). Po, Polymorphic layer of the dentate gyrus; CA4,
field of the Ammon’s horn; II and VI, layers of the cerebral neocortex; LV, lateral ventricle; ChP, choroid plexus; Ep, ependymocytes. Arrowheads
point to giant neurons in the reticular formation giganto cellularis. Scale bars, 100 m.
FIG. 4. Simultaneous detection of p29 and D2 mRNAs. Double in situ hybridization with a p29 digoxigenin-labeled riboprobe (blue staining)
and a D2 radioactively labeled riboprobe (hybridization grains). The upper panels show bright-field, and the lower panels, dark-field images.
I–II, Layers of retrosplenial cortex; DG, dentate gyrus; CA4, field of Ammon’s horn; Po, polymorphic layer of the dentate gyrus; Mol, molecular
layer of the dentate gyrus. Arrows point to p29 mRNA signal in layer II of the retrosplenial cortex and in tanycytes somas and in meninges.
Arrowheads point to D2 mRNA signal in tanycytes somas (white) and tanycytes feet (black) at the median eminence. Scale bars, 150 m.
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Both T4 and T3 can enter the brain through the blood-brain
and the cerebrospinal fluid-brain barriers (43). The passage
through the blood-CSF barrier, i.e. through the epithelial cells
lining the ventricular side of the choroid plexus, was thought
to be facilitated by locally synthesized transthyretin. How-
ever, results from transthyretin knockout animals do not
support this hypothesis (44, 45). p29 was originally identified
as a putative T4-binding protein (15). If indeed p29 binds T4
in vivo, then its expression in cells lining the brain-CSF in-
terface may suggest a function of p29 in T4 transport to and
from the CSF. More studies are clearly needed to explore this
possibility.
Rat p29 shows very high sequence similarity with mouse
Dkk-3, a member of the Dikkopf protein family, which have
a role during Xenopus development (23). Given their high
sequence similarity, p29 might be considered as the rat ho-
molog of Dkk-3. In fact, the p29 sequence appears in the
GenBank database defined as the rat Dkk-3 homolog with
accession no. NM_138519. On the other hand, the derived
protein sequence lacks the signal peptide that makes all
Dickkopf family members secreted glycoproteins. Close
comparison of the reported p29 sequence with that of mouse
Dkk-3, however, reveals a high sequence similarity, with
conserved nucleotide substitutions also in the region encod-
ing the Dkk-3 signal peptide. Dkk-3 is expressed in the ven-
tricular zones of developing brain and spinal chord (24),
resembling the ventricular localization of p29 found in the
postnatal rat brain. Although expression of mouse Dkk-3 has
not been studied in detail, in the adult it is expressed in the
hippocampus and cerebral neocortex in a pattern very sim-
ilar to that described for p29 in our work (23).
In summary, we found that in most regions of the brain p29
and D2 show dissimilar distributions. This argues against the
hypothesis that p29 is part of a D2 multienzyme complex.
Related functions for p29, such as a role in T4 transport,
cannot be discarded. Such a role would be compatible with
its prominent expression in cells lining the choroid plexuses
and the walls of the ventricles.
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